Cannabinoid Pharmaceuticals for Tourette Syndrome and Other Diseases are Making Continued Progress

Therapix Biosciences specializes in cannabinoid pharmaceuticals. Currently, they are working on developing a therapy called tetrahydrocannabinol or THX-110 as a treatment for Tourette syndrome (TS). Additionally, it is being developed…

Continue Reading Cannabinoid Pharmaceuticals for Tourette Syndrome and Other Diseases are Making Continued Progress
The Results From This Immune Thrombocytopenia Trial are Good News for Patients
source: pixabay.com

The Results From This Immune Thrombocytopenia Trial are Good News for Patients

According to a story from ucb.com, the biopharmaceutical company UCB has recently released the final results from its phase 2 clinical trial which tested the company's investigational monoclonal antibody rozanolixizumab…

Continue Reading The Results From This Immune Thrombocytopenia Trial are Good News for Patients